Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Viracta Therapeutics (formerly Sunesis) Address
2533 S. Coast Hwy 101 Cardiff-by-the-Sea, CA United States